Treatment of Laryngotracheal Stenosis Using Mesenchymal Stem Cells

Status Completed

Clinical Trial Summary

The trial evaluates the safety and efficacy of the olfactory mucosa-derived mesenchymal stem cells based therapy for the patients with chronic laryngeal and tracheal stenosis

Clinical Trial Description

Trial evaluating the safety and efficacy of olfactory mucosa-derived mesenchymal stem cells based therapy for the patients with chronic laryngeal and tracheal stenosis.

Mesenchymal stem cells are obtained from tissue biopsy of olfactory mucosa using explant method. Biomass of autologous mesenchymal stem cells in 10% human albumin solution is injected submucosally around and over the tissue after removal of a granuloma tissue during surgical intervention. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03130374
Study type	Interventional
Source	The Republican Research and Practical Center for Epidemiology and Microbiology
Contact
Status	Completed
Phase	Phase 1/Phase 2
Start date	January 3, 2017
Completion date	May 20, 2019

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT01219465` - Umbilical Cord Mesenchymal Stem Cells Infusion for Initial Type 1 Diabetes Mellitus	Phase 1/Phase 2
Active, not recruiting	`NCT01221428` - Umbilical Cord Mesenchymal Stem Cells Infusion for Ulcerative Colitis	Phase 1/Phase 2
Completed	`NCT03105284` - Adipose-tissue Derived Stem Cells in Flaps Versus Liposuction	N/A
Not yet recruiting	`NCT01224327` - Umbilical Cord Mesenchymal Stem Cells Infusion Via Hepatic Artery in Cirrhosis Patients	Phase 1/Phase 2
Recruiting	`NCT06149832` - Treatment of Oral Chronic Graft-versus-host Disease With Human Umbilical Cord Mesenchymal Stem Cell Dressing	Phase 4
Recruiting	`NCT05165459` - Open Label Single Arm Proof of Concept Trial to Evaluate the Efficacy and Safety of Cytori Celution System in Chronic Non-Healing Venous Leg Ulcers	N/A
Active, not recruiting	`NCT04014166` - Study of Human Umbilical Cord-derived Mesenchymal Stem Cells for Treatment of Refractory Immune Thrombocytopenia	N/A
Not yet recruiting	`NCT06077734` - Muscle Stem Cell Quality in Atrophy
Completed	`NCT00956891` - Therapeutic Effects of Liver Failure Patients Caused by Chronic Hepatitis B After Autologous MSCs Transplantation	Phase 1/Phase 2
Recruiting	`NCT01218464` - Safety and Efficacy of Human Mesenchymal Stem Cells for Treatment of Liver Failure	Phase 1/Phase 2
Active, not recruiting	`NCT03874572` - Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth	Phase 1
Recruiting	`NCT00953485` - Allogeneic Mesenchymal Stem Cells Transplantation for Primary Sjögren's Syndrome (pSS)	Phase 1/Phase 2
Not yet recruiting	`NCT04863183` - Cell Therapy With Cellistem-OA for Symptomatic Knee Osteoarthritis	Phase 1/Phase 2
Completed	`NCT06360861` - Evaluate the Safety and Feasibility of Allogeneic Mesenchymal Stem Cells in Patients With Multiple Sclerosis	Phase 1
Completed	`NCT05018754` - Treatment of Oral Mucositis Using Platelet Rich Fibrin TREATMENT OF ORAL MUCOSITIS USING PRF
Recruiting	`NCT04356287` - Treatment With Human Umbilical Cord-derived Mesenchymal Stromal Cells in Systemic Sclerosis	Phase 1/Phase 2
Active, not recruiting	`NCT02673788` - Follow-Up Study of Safety of Pneumostem® in Premature Infants With Intraventricular Hemorrhage
Recruiting	`NCT01763086` - Mesenchymal Stem Cells for Treatment of Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplant	Phase 2
Recruiting	`NCT01763099` - Mesenchymal Stem Cells Combined With Cord Blood for Treatment of Graft Failure	Phase 2
Completed	`NCT02302599` - Mesenchymal Stem Cells to Treat Type 2 Diabetes	Phase 2